Regeneron Pharmaceuticals Inc.

07/29/2021 | Press release | Distributed by Public on 07/28/2021 23:03

Dupixent® (dupilumab) Significantly Improved Itch and Hives in Patients with Chronic Spontaneous Urticaria, a Step Forward in Demonstrating the Role of Type 2 Inflammation in[...]